Minister Nitin Gadkari Inaugurates Horiba’s Greenfield Manufacturing Plant in Nagpur
Nitin Gadkari | HORIBA manufacturing plant: In a significant boost to the “Make in India” initiative, Union Minister of Road and Transport, Nitin Gadkari, inaugurated one of India’s largest medical equipment and hematology reagent manufacturing units by HORIBA India in Butibori, Nagpur. This event marks a major milestone in India’s journey towards becoming a global manufacturing hub.
A New Era for Medical Manufacturing in India (HORIBA manufacturing plant)
HORIBA Group, a Japan-headquartered conglomerate, has established its third manufacturing facility in India with this new plant in Nagpur. This state-of-the-art facility, sprawling over 50,000 square meters, is set to revolutionize the medical equipment industry in India.
Significance of the New Facility
“The futuristic vision with futuristic technology. India is the fastest growing economy in the world, and that’s why we want to bring the latest technology here. India is the perfect place for development, with its trained manpower and young talent,” said Gadkari during the inauguration.
Investment and Economic Impact
With an investment of Rs 200 crore, the Nagpur facility is poised to serve over 30,000 diagnostic labs and hospitals across India. This substantial investment underscores HORIBA’s commitment to the Indian market and the broader “Make in India” initiative.
The Vision Behind the Inauguration
Deputy Chief Minister of Maharashtra, Devendra Fadnavis, who also attended the event, highlighted the rapid growth of the medical devices sector in India. “India, once a net importer of medical devices, is now a significant exporter. Our exports in the sector are nearing USD 10 billion with an annual growth rate of around 10 percent. India is also emerging as a top medical tourism destination,” he said.
Facility Features and Capabilities
The Nagpur plant includes production units for blood diagnostics, clinical chemistry equipment, and medical consumables. It also houses the HORIBA India Technical Institute, offering biomedical learning programs through a partnership with Nagpur University, and the HORIBA Experience Zone, showcasing the full range of HORIBA healthcare equipment.
Educational and Training Initiatives
The facility features an international training center and a central warehouse. Currently employing 100 people, this number is expected to nearly double in the next five years, creating significant employment opportunities in the region.
Localization and Export Plans (Nitin Gadkari)
This facility will serve as an export hub to neighboring countries, starting with a target of 50% localization, which will later increase to around 80-90%. This strategic move will play a crucial role in reducing turnaround time and minimizing costs by promoting local production.
Supporting Government Initiatives
“The facility will support the Government’s initiative to enhance ‘Make in India’ and Self-Reliance. It aims to become a one-stop solution for India, initially catering to the Bio & Healthcare segment, with future plans to expand into the Materials & Semiconductor and Energy & Environment sectors,” said Jai Hakhu, Board of Directors, HORIBA Ltd., Japan and Chairman, HORIBA India.
A Step Towards Self-Reliance (Nitin Gadkari)
This initiative is a significant step towards reducing India’s dependency on imported medical devices, fostering innovation, and boosting the local economy. The state-of-the-art manufacturing processes and the focus on localization will ensure high-quality products at competitive prices.
Economic and Social Benefits
The establishment of the Nagpur facility is not just a business expansion for HORIBA but a monumental stride in India’s journey towards self-reliance. By leveraging local talent and resources, HORIBA is setting a benchmark for other global companies to follow.
Future Expansion Plans
HORIBA’s commitment to India is evident through its continuous investments and future expansion plans. The company aims to diversify its product portfolio and enter new segments, including Materials & Semiconductor and Energy & Environment sectors.
The inauguration of HORIBA’s Greenfield manufacturing plant in Nagpur is a testament to India’s growing prominence in the global medical manufacturing landscape. It aligns with the government’s vision of “Make in India” and showcases the potential of Indian talent and innovation. This facility is set to not only cater to the domestic market but also position India as a key player in the global medical equipment industry.
1. What is the significance of the new HORIBA facility in Nagpur?
The new HORIBA facility in Nagpur is significant as it is one of India’s largest medical equipment and hematology reagent manufacturing units, supporting the “Make in India” initiative and aiming to serve over 30,000 diagnostic labs and hospitals across the country.
2. How does the new facility support the “Make in India” initiative?
The facility supports the “Make in India” initiative by promoting local production, reducing turnaround time, minimizing costs, and fostering self-reliance in the medical equipment sector.
3. What are the future plans for the HORIBA facility in Nagpur?
The future plans for the HORIBA facility include increasing localization to 80-90%, serving as an export hub, and expanding into new segments such as Materials & Semiconductor and Energy & Environment sectors.
4. How will the new facility impact employment in Nagpur?
The new facility currently employs 100 people, with plans to nearly double this number in the next five years, significantly boosting employment opportunities in the region.
5. What educational initiatives are associated with the HORIBA facility?
The facility includes the HORIBA India Technical Institute, which offers biomedical learning programs through a partnership with Nagpur University, and the HORIBA Experience Zone, which showcases the full range of HORIBA healthcare equipment.
